UBS Reiterates Neutral Rating on Vifor Pharma AG (VIFN:SW) (GNHAY)

November 19, 2020 4:41 AM EST
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%


Trade Now! 
Join SI Premium – FREE

UBS analyst Laura Sutcliffe reiterated a Neutral rating and CHF129.00 price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY).


You May Also Be Interested In





Related Categories

Intl Ratings